Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Bovine Colostrum to Prevent Absorption of Gluten [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial using bovine colostrum to prevent gluten absorption has been suspended, targeting individuals with celiac disease and gluten sensitivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bovine colostrum (bovine colostrum)

Snippet

Sponsor: Milky Way Life Sciences LLC | Conditions: Celiac Disease, Gluten Sensitivity | EARLY_Phase 1 | Status: SUSPENDED